Association between metabolic overweight/obesity phenotypes and readmission risk in patients with Immune Thrombocytopenia (ITP): a national retrospective study.
5 affiliations
- 1Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No. 324, Jingwu Road, Jinan, Shandong, 250021, China.
- 2Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China.
- 3Department of Urology, The First Affiliated Hospital of Shandong First Medical University, Shandong Provincial Qianfoshan Hospital, Jinan, China.
- 4Department of Hematology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, 250021, China.
- 5Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No. 324, Jingwu Road, Jinan, Shandong, 250021, China. [email protected].
Abstract
Immune thrombocytopenia (ITP) is one of the most common autoimmune hemorrhagic disorders and is characterized by frequent relapses that require repeated hospitalization. Although overweight/obesity and metabolic disorders have been linked to ITP, their association with readmission risk remains unclear. A cohort of 3,811 patients with a discharge diagnosis of ITP was identified from the National Readmission Database (NRD) for this retrospective analysis. Patients were classified into four phenotypes according to overweight/obesity status and metabolic status: metabolically healthy non-obese (MHNO), metabolically unhealthy non-obese (MUNO), metabolically healthy obese (MHO), and metabolically unhealthy obese (MUO). Readmissions were assessed at 30, 60, 90, 120, 150, and 180 days. Multivariable Cox proportional hazards models were used to evaluate the association between metabolic overweight/obesity phenotypes and readmission risk in this cohort. At 120, 150, and 180 days, patients with metabolically unhealthy phenotypes had a significantly higher risk of readmission than those with the MHNO phenotype. In contrast, the MHO phenotype was not associated with increased readmission risk. Subsequent stratified analyses showed a gradual increase in readmission risk with a higher number of concurrent metabolic risk factors. Among patients with ITP, metabolic disorders, rather than overweight/obesity, were associated with an increased risk of readmission after multivariable adjustment. Readmission risk also increased with the number of concurrent metabolic risk factors. Notably, the association between metabolic comorbidities and ITP-related readmission showed a distinct time-dependent pattern. Because this study did not include a non-ITP control group, whether this association is specific to ITP or reflects a broader effect of metabolic comorbidities on readmission remains uncertain.
Related
- Association between overweight and obesity and the frequency of general practice consultations among children aged 2–17 years: a French retrospective cohort study
- Machine Learning Prediction of 90-Day Readmission and Mortality in General Internal Medicine: A Retrospective Cohort Study
- Multidisciplinary nurse-led transitional care and 30-day readmission in patients with heart failure: a retrospective cohort study
- Treatment context is associated with thrombocytopenia report phenotypes in lung cancer: an active-comparator analysis of FAERS and JADER
- Cardiovascular and comorbid risk factors for thrombosis in primary immune thrombocytopenia: a single-center retrospective study
BibTeX
@article{xu2026association,
title = {{Association between metabolic overweight/obesity phenotypes and readmission risk in patients with Immune Thrombocytopenia (ITP): a national retrospective study.}},
author = {Fuxin Xu and Tongxin Wang and Lingquan Meng and Cheng Zhang and Xin Zhou and Xiangxiang Zhou and Panpan Han},
journal = {Annals of hematology},
year = {2026},
month = jul,
doi = {10.1007/s00277-026-07182-y},
url = {https://europepmc.org/article/MED/42897349},
note = {CC BY},
}
RIS
TY - JOUR
TI - Association between metabolic overweight/obesity phenotypes and readmission risk in patients with Immune Thrombocytopenia (ITP): a national retrospective study.
AU - Fuxin Xu
AU - Tongxin Wang
AU - Lingquan Meng
AU - Cheng Zhang
AU - Xin Zhou
AU - Xiangxiang Zhou
AU - Panpan Han
PY - 2026
DA - 2026/07/01
JO - Annals of hematology
DO - 10.1007/s00277-026-07182-y
UR - https://europepmc.org/article/MED/42897349
AB - Immune thrombocytopenia (ITP) is one of the most common autoimmune hemorrhagic disorders and is characterized by frequent relapses that require repeated hospitalization. Although overweight/obesity and metabolic disorders have been linked to ITP, their association with readmission risk remains unclear. A cohort of 3,811 patients with a discharge diagnosis of ITP was identified from the National Readmission Database (NRD) for this retrospective analysis. Patients were classified into four phenotypes according to overweight/obesity status and metabolic status: metabolically healthy non-obese (MHNO), metabolically unhealthy non-obese (MUNO), metabolically healthy obese (MHO), and metabolically unhealthy obese (MUO). Readmissions were assessed at 30, 60, 90, 120, 150, and 180 days. Multivariable Cox proportional hazards models were used to evaluate the association between metabolic overweight/obesity phenotypes and readmission risk in this cohort. At 120, 150, and 180 days, patients with metabolically unhealthy phenotypes had a significantly higher risk of readmission than those with the MHNO phenotype. In contrast, the MHO phenotype was not associated with increased readmission risk. Subsequent stratified analyses showed a gradual increase in readmission risk with a higher number of concurrent metabolic risk factors. Among patients with ITP, metabolic disorders, rather than overweight/obesity, were associated with an increased risk of readmission after multivariable adjustment. Readmission risk also increased with the number of concurrent metabolic risk factors. Notably, the association between metabolic comorbidities and ITP-related readmission showed a distinct time-dependent pattern. Because this study did not include a non-ITP control group, whether this association is specific to ITP or reflects a broader effect of metabolic comorbidities on readmission remains uncertain.
SN - 0939-5555
SN - 1432-0584
ER -